Authors
Innovation is essential in drug development but is not cheap. Robin Ferner, Dyfrig Hughes, and Jeffrey Aronson examine the challenges of encouraging innovation while ensuring clinical benefit
No takes yet. Share an insight, caveat, or question.
Ferner et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: